Drug shortages, foreign manufacturing and supply chain vulnerability were a common, intertwined thread throughout the appropriations subcommittee hearing. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
